TriSalus Life Sciences TLSI is preparing to release its quarterly earnings on Thursday, 2024-11-14. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect TriSalus Life Sciences to report an earnings per share (EPS) of $-0.34.
Anticipation surrounds TriSalus Life Sciences's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.28, leading to a 0.64% increase in the share price on the subsequent day.
Here's a look at TriSalus Life Sciences's past performance and the resulting price change:
Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
EPS Estimate | -0.49 | -0.72 | -0.69 | |
EPS Actual | -0.21 | -0.60 | -1.56 | -0.13 |
Price Change % | 1.0% | 3.0% | -4.0% | -2.0% |
Performance of TriSalus Life Sciences Shares
Shares of TriSalus Life Sciences were trading at $4.46 as of November 12. Over the last 52-week period, shares are up 12.41%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for TriSalus Life Sciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.